Livia Garavelli

Dr. Livia Garavelli

Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JHJeroen K J Van Houdt
Jeroen K J Van Houdt
BNBeata Anna Nowakowska
Beata Anna Nowakowska
SSSérgio B Sousa
Sérgio B Sousa
BSBarbera D C van Schaik
Barbera D C van Schaik
ESEve Seuntjens
Eve Seuntjens
JVJoris Robert Vermeesch
Joris Robert Vermeesch

16 June 2016 in JCI Insight
Verified
Journal Article
Open access
PDF file
GMGhayda Mirzaa
Ghayda Mirzaa
ATAndrew E. Timms
Andrew E. Timms
VCValerio Conti
Valerio Conti
EBEvan August Boyle
Evan August Boyle
KGKatta M. Girisha
Katta M. Girisha
WDWilliam B. Dobyns
William B. Dobyns
Mosaicism is increasingly recognized as a cause of developmental disorders with the advent of next-generation sequencing (NGS). Mosaic mutations of PIK3CA have been associated with the widest spectrum of phenotypes associated with overgrowth and vascular malformations. We performed targeted NGS using 2 independent deep-coverage methods that utilize molecular inversion probes and amplicon sequencing in a cohort of 241 samples from 181 individuals with brain and/or body overgrowth. We identified PIK3CA mutations in 60 individuals. Several other individuals ( n = 12) were identified separately to have mutations in PIK3CA by clinical targeted-panel testing ( n = 6), whole-exome sequencing ( n = 5), or Sanger sequencing ( n = 1). Based on the clinical and molecular features, this cohort segregated into three distinct groups: (a) severe focal overgrowth due to low-level but highly activating (hotspot) mutations, (b) predominantly brain overgrowth and less severe somatic overgrowth due to less-activating mutations, and (c) intermediate phenotypes (capillary malformations with overgrowth) with intermediately activating mutations. Sixteen of 29 PIK3CA mutations were novel. We also identified constitutional PIK3CA mutations in 10 patients. Our molecular data, combined with review of the literature, show that PIK3CA -related overgrowth disorders comprise a discontinuous spectrum of disorders that correlate with the severity and distribution of mutations.

23 May 2016 in Nature Genetics
Verified
Journal Article
Closed access
CKClara D M van Karnebeek
Clara D M van Karnebeek
LBLuisa Bonafé
Luisa Bonafé
XWXiao-Yan Wen
Xiao-Yan Wen
MTMaja Taralo-Graovac
Maja Taralo-Graovac
SBSara Balzano
Sara Balzano
ASAndrea Superti-Furga
Andrea Superti-Furga

7 June 2014 in Human Genetics
Verified
Journal Article
Closed access
PDF file
MAMariëlle Alders
Mariëlle Alders
LALihadh Al-Gazali
Lihadh Al-Gazali
ICIsabelle Cordeiro
Isabelle Cordeiro
BDBruno Dallapiccola
Bruno Dallapiccola
LGLivia Garavelli
Livia Garavelli
RHRaoul C. Hennekam
Raoul C. Hennekam

13 March 2014 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
AFAntonella Forlino
Antonella Forlino
AVAnnalisa Vetro
Annalisa Vetro
LGLivia Garavelli
Livia Garavelli
RCRoberto Ciccone
Roberto Ciccone
ELEdra London
Edra London
OZorsetta zuffardi
orsetta zuffardi
Beuschlein et al. report a gain of function in PRKACA, the catalytic subunit alpha (Cα) of the cyclic AMP (cAMP)–dependent protein kinase (protein kinase A [PKA]) in cortisol-producing adenomas and micronodular adrenocortical hyperplasia.1 Micronodular adrenocortical hyperplasia is also associated with Carney complex and inactivating mutations of the PKA regulatory subunit RIα (encoded by PRKAR1A).2,3

24 October 2007 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
LGLivia Garavelli
Livia Garavelli
PMPaola Cerruti Mainardi
Paola Cerruti Mainardi
Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly syndrome characterized by a distinct facial phenotype (high forehead, frontal bossing, large eyebrows, medially flaring and sparse in the middle part, hypertelorism, deep set but large eyes, large and uplifted ear lobes, with a central depression, saddle nose with prominent rounded nasal tip, prominent columella, open mouth, with M-shaped upper lip, frequent smiling, and a prominent but narrow and triangular pointed chin), moderate-to-severe intellectual deficiency, epilepsy and variable congenital malformations including Hirschsprung disease (HSCR), genitourinary anomalies (in particular hypospadias in males), congenital heart defects, agenesis of the corpus callosum and eye anomalies. The prevalence of MWS is currently unknown, but 171 patients have been reported so far. It seems probable that MWS is under-diagnosed, particularly in patients without HSCR. MWS is caused by heterozygous mutations or deletions in the Zinc finger E-box-binding homeobox 2 gene, ZEB2, previously called ZFHX1B (SIP1). To date, over 100 deletions/mutations have been reported in patients with a typical phenotype; they are frequently whole gene deletions or truncating mutations, suggesting that haploinsufficiency is the main pathological mechanism. Studies of genotype-phenotype analysis show that facial gestalt and delayed psychomotor development are constant clinical features, while the frequent and severe congenital malformations are variable. In a small number of patients, unusual mutations can lead to an atypical phenotype. The facial phenotype is particularly important for the initial clinical diagnosis and provides the hallmark warranting ZEB2 mutational analysis, even in the absence of HSCR. The majority of MWS cases reported so far were sporadic, therefore the recurrence risk is low. Nevertheless, rare cases of sibling recurrence have been observed. Congenital malformations and seizures require precocious clinical investigation with intervention of several specialists (including neonatologists and pediatricians). Psychomotor development is delayed in all patients, therefore rehabilitation (physical therapy, psychomotor and speech therapy) should be started as soon as possible.